Rexahn Pharmaceuticals, Inc. to Present at The Robins Group Emerging Opportunities Investment Conference in New York City
ROCKVILLE, Md.--(BUSINESS WIRE)--
Rexahn Pharmaceuticals, Inc. (OTC BB:RXHN), a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for cancer, central nervous system disorders, sexual dysfunction and other unmet medical needs, today announced that Chang H. Ahn, Ph.D., Chairman and Chief Executive Officer of the Company, will be presenting an overview of Rexahn Pharmaceuticals at The Robins Group Emerging Opportunities Investment Conference on Thursday, May 24 at 11:00 am Eastern Time at the University Club in New York City.
About Rexahn Pharmaceuticals, Inc.
Rexahn Pharmaceuticals is a biopharmaceutical company leveraging its unique technology platform to discover, develop and commercialize innovative treatments for cancer, central nervous system disorders, sexual dysfunction and other unmet medical needs. Rexahn's compounds are designed to uniquely treat various disease states while significantly minimizing side effects in order to allow patients to regain quality of life through therapy. For Additional information about Rexahn visit www.rexahn.com.
Source: Rexahn Pharmaceuticals, Inc.
Released May 23, 2007